FDA Ginseng Labeling Enforcement Stressed In House Ag Approps Bill
This article was originally published in The Tan Sheet
Executive Summary
FDA needs to take a more active approach to ensure that herbs that do not fall under the Panax genus are not labeled as "ginseng," the House Appropriations Committee states in its report on the FY 2003 Agriculture Appropriations bill
You may also be interested in...
FDA Radiation Label Change Positive, But “Material Change” Issue Troubling
FDA's proposal to revise labeling regulations for irradiated dietary supplements and food products could ease label requirements, but how the regulation would measure "material change" from radiation leaves the possibility for a bigger burden, trade groups say
FDA Radiation Label Change Positive, But “Material Change” Issue Troubling
FDA's proposal to revise labeling regulations for irradiated dietary supplements and food products could ease label requirements, but how the regulation would measure "material change" from radiation leaves the possibility for a bigger burden, trade groups say
FDA Radiation Label Change Positive, But “Material Change” Issue Troubling
FDA's proposal to revise labeling regulations for irradiated dietary supplements and food products could ease label requirements, but how the regulation would measure "material change" from radiation leaves the possibility for a bigger burden, trade groups say